CLE-030
CLE-030 is a KCNQ2 agonist with non-gating-dependent current-modulating activity. CLE-030 modulates neuronal network activity. CLE-030 can be used in studies related to pain, epilepsy and benign familial neonatal convulsions.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2803111-66-0
- Formule: C20H20Br2N4OS2
- Masse moléculaire:556.34
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
CLE-030 (Compound 34) (10 μM; for at least 3 min) increases channel currents in CHO-K1 cells transfected with human KCNQ2[1].
CLE-030 (0.1-10 μM) potently activates wild-type human KCNQ2 channels expressed in CHO cells, with an EC50 of 3.9 μM. It enhances channel currents without altering voltage sensitivity or gating kinetics[2].
CLE-030 (0.1-10 μM) shows significantly reduced activation potency toward W236A, L299A, and V302A mutant KCNQ2 channels expressed in CHO cells[2].
CLE-030 (0.1-10 μM) selectively activates human KCNQ2, KCNQ4 and KCNQ5 channels expressed in CHO cells, and exhibits no significant activity against KCNQ1, KCNQ3A315T, BKCa, Kv1.2, Kir4.1 or TREK-1 channels[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2803111-66-0
-
Masse moléculaire 556.34
-
Formule C20H20Br2N4OS2
-
SMILES
O=C(CSC1=NN=C(CSCC2=CC=C(C)C=C2)N1C)NC3=CC=C(C=C3Br)Br
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)